218 related articles for article (PubMed ID: 26772441)
1. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
[TBL] [Abstract][Full Text] [Related]
2. Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.
Wethal T; Lund MB; Edvardsen T; Fosså SD; Pripp AH; Holte H; Kjekshus J; Fosså A
Br J Cancer; 2009 Aug; 101(4):575-81. PubMed ID: 19623176
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma.
Cella L; Liuzzi R; Conson M; Torre G; Caterino M; De Rosa N; Picardi M; Camera L; Solla R; Farella A; Salvatore M; Pacelli R
Radiother Oncol; 2011 Nov; 101(2):316-21. PubMed ID: 21925755
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
6. Changes of the Heart Valves in the Long Term After Chemoradiotherapy According to Different Protocols for Hodgkin's Lymphoma in Children and Adolescents.
Parkhomenko RA; Shcherbenko OI; Rybakova MK; Zelinskaya NI; Kharchenko NV; Kunda MA; Zapirov GM
J Adolesc Young Adult Oncol; 2019 Aug; 8(4):410-416. PubMed ID: 31017511
[No Abstract] [Full Text] [Related]
7. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
Hull MC; Morris CG; Pepine CJ; Mendenhall NP
JAMA; 2003 Dec; 290(21):2831-7. PubMed ID: 14657067
[TBL] [Abstract][Full Text] [Related]
8. Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study.
Murbraech K; Wethal T; Smeland KB; Holte H; Loge JH; Holte E; Rösner A; Dalen H; Kiserud CE; Aakhus S
JACC Cardiovasc Imaging; 2016 Mar; 9(3):230-9. PubMed ID: 26897666
[TBL] [Abstract][Full Text] [Related]
9. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic cardiac disease following mediastinal irradiation.
Heidenreich PA; Hancock SL; Lee BK; Mariscal CS; Schnittger I
J Am Coll Cardiol; 2003 Aug; 42(4):743-9. PubMed ID: 12932613
[TBL] [Abstract][Full Text] [Related]
11. The risk of reoperative cardiac surgery in radiation-induced valvular disease.
Ejiofor JI; Ramirez-Del Val F; Nohria A; Norman A; McGurk S; Aranki SF; Shekar P; Cohn LH; Kaneko T
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1883-1895. PubMed ID: 28870399
[TBL] [Abstract][Full Text] [Related]
12. Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors.
Cella L; Liuzzi R; Conson M; D'Avino V; Salvatore M; Pacelli R
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):304-10. PubMed ID: 23886419
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
[TBL] [Abstract][Full Text] [Related]
14. Clinical and subclinical cardiac late effects in pediatric Hodgkin's lymphoma survivors.
Materazzo C; Massimino M; Schiavello E; Podda M; Gandola L; Cefalo G; Catania S; Meazza C; Moschetti I; Terenziani M
Tumori; 2017 Nov; 103(6):566-571. PubMed ID: 28708228
[TBL] [Abstract][Full Text] [Related]
15. Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma.
Andersen R; Wethal T; Günther A; Fosså A; Edvardsen T; Fosså SD; Kjekshus J
Am J Cardiol; 2010 Jan; 105(2):149-52. PubMed ID: 20102909
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
17. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease.
van Leeuwen-Segarceanu EM; Bos WJ; Dorresteijn LD; Rensing BJ; der Heyden JA; Vogels OJ; Biesma DH
Cancer Treat Rev; 2011 Aug; 37(5):391-403. PubMed ID: 21333452
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
Cella L; Liuzzi R; D'Avino V; Conson M; Di Biase A; Picardi M; Pugliese N; Solla R; Salvatore M; Pacelli R
Acta Oncol; 2014 May; 53(5):613-9. PubMed ID: 24195693
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
20. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.
Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
Am J Hematol; 2017 Mar; 92(3):251-258. PubMed ID: 28006849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
